Jin‐Hao Yang
Impact in
- Otorhinolaryngology top 5%
- Head and Neck Cancer Studies
- Immunology top 5%
- Immunotherapy and Immune Responses
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
Papers in
-
- Head and Neck Cancer Studies 7
-
- Cancer Research and Treatments 2
- Co-authors
- William Marston Linehan (3 shared papers)Douglas J. Schwartzentruber (3 shared papers)Suzanne Louise Topalian (3 shared papers)James J. Mulé (3 shared papers)Steven A. Rosenberg (3 shared papers)S.F. Leitman (1 shared paper)Seth M. Steinberg (1 shared paper)Paul M. Aebersold (1 shared paper)
- Journals
- BMC Cancer (3 papers)Human Gene Therapy (2 papers)Radiotherapy and Oncology (2 papers)Clinical & Translational Oncology (1 paper)Nature Metabolism (1 paper)
- Partner nations
- ChinaUnited StatesFrance
In The Last Decade
Jin‐Hao Yang
25 papers receiving 1.0k citations
Jin‐Hao Yang's Hit Papers
Peers
Comparison fields: 5 of 78
- Otorhinolaryngology 125
- Immunology 494
- Oncology 464
- Biotechnology 54
- Cancer Research 82
Countries citing papers authored by Jin‐Hao Yang
This map shows the geographic impact of Jin‐Hao Yang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jin‐Hao Yang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jin‐Hao Yang more than expected).
Fields of papers citing papers by Jin‐Hao Yang
This network shows the impact of papers produced by Jin‐Hao Yang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jin‐Hao Yang. The network helps show where Jin‐Hao Yang may publish in the future.
Co-authors
The 25 scholars most cited alongside Jin‐Hao Yang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Prospective Randomized Trial of High-Dose Interleukin-2 Alone or in Conjunction With Lymphokine-Activated Killer Cells for the Treatment of Patients With Advanced Cancer Hit paper breakdown → | 1993 | 512 |
| 2 | 1987 | 193 | |
| 3 | 2019 | 60 | |
| 4 | 2018 | 54 | |
| 5 | 1992 | 43 | |
| 6 | 1992 | 38 | |
| 7 | 2020 | 38 | |
| 8 | 2023 | 26 | |
| 9 | 2021 | 24 | |
| 10 | 2023 | 22 | |
| 11 | 2024 | 19 | |
| 12 | 2021 | 18 | |
| 13 | 2022 | 16 | |
| 14 | 2020 | 7 | |
| 15 | 2023 | 7 | |
| 16 | 2020 | 5 | |
| 17 | 2021 | 5 | |
| 18 | 2023 | 5 | |
| 19 | 2021 | 3 | |
| 20 | 2023 | 3 |
About Jin‐Hao Yang
Jin‐Hao Yang is a scholar working on Otorhinolaryngology, Biotechnology, Immunology, Health, Toxicology and Mutagenesis and Infectious Diseases, having authored 29 papers that have together received 1.1k indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (7 papers), Cancer Research and Treatments (2 papers), Water Treatment and Disinfection (2 papers), Mycobacterium research and diagnosis (2 papers), Immunotherapy and Immune Responses (2 papers), Virus-based gene therapy research (2 papers), Glycosylation and Glycoproteins Research (1 paper) and Inflammatory Biomarkers in Disease Prognosis (1 paper). The work is most often cited by research in Otorhinolaryngology (125 citations), Immunology (494 citations), Oncology (464 citations), Biotechnology (54 citations) and Cancer Research (82 citations). Jin‐Hao Yang has collaborated with scholars based in China, United States and France. Frequent co-authors include William Marston Linehan, Douglas J. Schwartzentruber, Suzanne Louise Topalian, James J. Mulé, Steven A. Rosenberg, S.F. Leitman, Seth M. Steinberg, Paul M. Aebersold, Claudia A. Seipp and S A Rosenberg. Their work appears in journals such as BMC Cancer, Human Gene Therapy, Radiotherapy and Oncology, Clinical & Translational Oncology and Nature Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.